KCT0007589
Completed
未知
Development of machine learning/artificial intelligence algorithm that can select normal people and patients with mild cognitive impairment from fNIRS signals measured during olfactory stimulation in the prefrontal cortex
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Gwangju Institute of Science and Technology
- Enrollment
- 130
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •¦ Criteria for selection of research subjects
- •? Adult men and women with no physical or mental history other than dementia
- •(Age 45 or older – under 100\)
- •? Normal people with no symptoms of dementia
- •? Mild cognitive impairment
- •? Dementia patients
- •? Since this study establishes a system that can classify dementia severity and monitor the progress of dementia patients through the modeling of indicators related to brain function and behavior of dementia patients, it is difficult to analyze the significant characteristics as the severity corresponds to the terminal stage. Patients with difficult AD were not included in the initial study. However, if a subject corresponding to the severity level 0 to 4 in this study develops into a terminal AD patient, it may be included in the subject of the follow\-up/analysis study.
Exclusion Criteria
- •¦ Criteria for exclusion of study subjects
- •? If it is judged that the experiment is impossible because you cannot sit still for more than 10 minutes
- •? Elderly people with reduced sense of smell due to acute infection
- •? If you are unable to walk on your own due to severe gait disturbance
- •? When it is judged that the gait and balance\-related behavior experiment cannot be performed due to the high risk of falling
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Pathology AI PlatformKCT0003460Seoul National University Hospital6,200
Recruiting
Not Applicable
Development of Artificial Intelligence (AI) to accelerate Drug Target discoveryInterstitial Lung Disease including IPF (Idiopathic Pulmonary Fibrosis) Lung CancerJPRN-UMIN000041135ational Institutes of Biomedical Innovation, Health and Nutrition3,700
Not yet recruiting
Not Applicable
Research for Development of Artificial Intelligence-enhanced Electrocardiogram of Prediction fo r Mortality and Cardiovascular Outcomes using system of the National Health Insurance Service DatabaseNot ApplicableKCT0008493Inha University Hospital300,000
Recruiting
Not Applicable
Research on development of artificial intelligence (AI) for detection and classification of upper gastrointestinal cancers in endoscopic imagesupper gastrointestinal cancersJPRN-UMIN000039597agoya University200
Recruiting
Not Applicable
Development of artificial intelligence-based infrared thermographic software for the diagnosis of lumbosacral radiculopathyDiseases of the musculoskeletal system and connective tissueKCT0006880ational Health Insurance Service Ilsan Hospital1,600